Analgesic Effects of Midazolam in Human Volunteers — GabA01

Analgesic Drugs Clinical Trial

Official title:
A Single Center, Prospective, Randomized, Double Blind, Placebo-controlled, Three-way Cross-over Study of the Analgesic Effects of Midazolam Versus Placebo With Fentanyl as an Active Control in Human Volunteers

Status Completed

Clinical Trial Summary

This study evaluates analgesic properties of midazolam compared to placebo and fentanyl. Each participant will receive all three drugs (midazolam, fentanyl, placebo) on three different occasions (study visits) and the effect on different pain stimuli will be tested.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02629146
Study type	Interventional
Source	Wilhelminenspital Vienna
Contact
Status	Completed
Phase	Phase 4
Start date	December 2015
Completion date	March 2016

View Details

See also
	Status	Clinical Trial	Phase
	Enrolling by invitation	`NCT03184649` - Ibuprofen, Paracetamol Versus Placebo on Pain During Local Anesthetic Injection (RCT)	Phase 1/Phase 2
	Recruiting	`NCT03550599` - Adequacy of Pain Treatment in Radiotherapy